| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 181.97M | 223.18M | 193.25M | 184.95M | 159.43M | 181.54M |
| Gross Profit | 107.64M | 223.18M | 156.93M | 144.23M | 147.78M | 181.54M |
| EBITDA | 53.81M | 0.00 | 23.75M | 14.32M | 37.60M | 49.56M |
| Net Income | 30.31M | 35.96M | 18.07M | 11.08M | 30.14M | 39.80M |
Balance Sheet | ||||||
| Total Assets | 683.50M | 665.81M | 630.14M | 459.66M | 479.35M | 495.28M |
| Cash, Cash Equivalents and Short-Term Investments | 342.06M | 342.50M | 35.08M | 18.50M | 30.61M | 37.90M |
| Total Debt | 0.00 | 0.00 | 0.00 | 0.00 | 193.00K | 194.00K |
| Total Liabilities | 437.16M | 407.46M | 387.73M | 237.16M | 226.62M | 228.88M |
| Stockholders Equity | 246.34M | 258.35M | 242.41M | 222.50M | 252.73M | 266.40M |
Cash Flow | ||||||
| Free Cash Flow | -7.95M | 22.07M | 23.68M | 19.36M | 33.28M | 50.68M |
| Operating Cash Flow | -7.94M | 22.07M | 25.34M | 19.40M | 33.31M | 50.69M |
| Investing Cash Flow | 33.15M | 0.00 | -1.67M | -38.00K | -28.00K | -12.00K |
| Financing Cash Flow | -34.13M | -25.83M | -7.10M | -31.47M | -40.58M | -44.57M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | £1.50B | 8.36 | 15.18% | 11.03% | 8.78% | -38.83% | |
75 Outperform | £317.57M | 8.11 | 16.39% | 4.89% | 7.77% | 35.65% | |
72 Outperform | £705.49M | -67.29 | -2.53% | 8.03% | -48.03% | -289.17% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
66 Neutral | £2.24B | 34.62 | 5.21% | 1.22% | -7.30% | -27.69% | |
65 Neutral | £740.80M | -19.45 | -76.14% | ― | -35.05% | 74.73% | |
58 Neutral | £142.45M | 8.14 | ― | 2.90% | ― | ― |
Sabre Insurance Group plc has disclosed that three senior executives – chief executive Geoff Carter, claims director Trevor Webb and chief actuary Matt Wright – each acquired 149 ordinary shares in the company on 12 January 2026 through its HMRC-approved Share Incentive Plan, comprising 112 partnership shares purchased at 133.62p and 37 matching shares awarded at no cost. The transactions, which marginally increase management’s direct economic stake and align their interests further with shareholders, were carried out on the London Stock Exchange and reported under EU Market Abuse Regulation requirements, underscoring ongoing compliance with governance and transparency standards.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £147.00 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that its directors and persons discharging managerial responsibilities have acquired additional shares through the Company’s Share Incentive Plan. This move, involving key figures such as the CEO, Claims Director, and Chief Actuary, signifies a commitment to aligning management interests with shareholder value, potentially enhancing investor confidence.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.72 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that its directors and persons discharging managerial responsibilities have acquired additional shares in the company through its Share Incentive Plan. This plan allows employees to purchase shares using salary deductions and receive matching shares, which reflects the company’s commitment to employee investment and aligns management interests with those of shareholders.
The most recent analyst rating on (GB:SBRE) stock is a Hold with a £135.00 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has announced that as of 31 October 2025, its issued and fully paid share capital consists of 246,600,000 ordinary shares, each with a nominal value of £0.001 and one voting right per share. This update is crucial for shareholders as it determines the denominator for calculating their interest in the company under the Disclosure and Transparency Rules, impacting how they report changes in their holdings.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.62 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc announced that David Neave, a Non-executive Director, purchased 11,625 ordinary shares in the company at an average price of 130.61 pence per share. This transaction, conducted on the London Stock Exchange, represents 0.005 percent of the company’s issued share capital, indicating a modest increase in insider ownership which may reflect confidence in the company’s future performance.
The most recent analyst rating on (GB:SBRE) stock is a Buy with a £1.62 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.
Sabre Insurance Group plc has reiterated its full-year profit guidance, expecting results to align with 2024 figures, as it maintains strong pricing discipline and margin management. Despite a decrease in gross written premiums, the company has completed a £5 million share buyback and continues to generate strong capital, supporting its confidence in making an attractive capital distribution at year-end. The company is progressing well towards its Ambition 2030 goals, with expectations of market pricing increases in late 2025 or early 2026, which could bolster profitability in the coming years.
The most recent analyst rating on (GB:SBRE) stock is a Sell with a £1.16 price target. To see the full list of analyst forecasts on Sabre Insurance Group plc stock, see the GB:SBRE Stock Forecast page.